Related Experiment Videos
Age as a prognostic factor in recurrent breast cancer
Summary
Younger women with recurrent breast cancer, especially those under 35, face significantly shorter survival times. This age-related prognostic factor impacts outcomes even with other positive indicators.
Area of Science:
- Oncology
- Clinical Research
- Biostatistics
Background:
- Recurrent breast cancer presents unique prognostic challenges.
- Identifying reliable prognostic factors is crucial for patient management.
- Age has been an under-examined factor in breast cancer recurrence.
Purpose of the Study:
- To investigate the prognostic impact of age in patients with recurrent breast cancer.
- To analyze the relationship between age and survival outcomes.
- To compare survival across different age groups in recurrent breast cancer.
Main Methods:
- Analysis of 1,168 patients treated on Eastern Cooperative Oncology Group (ECOG) protocols.
- Evaluation of 18 prognostic factors, with a focus on age.
- Application of a Cox proportional hazards model for survival analysis.
Main Results:
- Survival was significantly shorter in patients younger than 35 years (P = .03).
- Younger age groups demonstrated shorter survival times, irrespective of menopausal status.
- Predicted median survival: <35 years (491 days), 36-45 years (590 days), >45 years (700 days).
Conclusions:
- Age is a significant independent prognostic factor in recurrent breast cancer.
- Younger patients (<35 years) experience poorer survival outcomes.
- Clinical strategies may need to consider age-specific approaches for recurrent breast cancer.